EV/EBITDA:
-3.31+0.06(+1.78%)Summary
- As of today, RXRX EV/EBITDA is -3.31, with a rise of +0.06 (+1.78%) during the most recent trading session on November 3, 2025.
- Over the past year, RXRX EV/EBITDA has increased by +0.95 (+22.30%).
- RXRX EV/EBITDA is now -101.83% below its all-time high of -1.64.
Performance
RXRX EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
RXRX EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise ValueEnterprise Value | PricePrice |
|---|---|---|---|
| 1D1 Day | +1.8% | -1.8% | -1.4% |
| 1M1 Month | +1.2% | -1.1% | -0.9% |
| 3M3 Months | +4.6% | -4.5% | -4.2% |
| 6M6 Months | +8.8% | +1.5% | -4.6% |
| YTDYTD | +35.6% | -11.7% | -19.5% |
| 1Y1 Year | +22.3% | +29.3% | -15.0% |
| 5Y5 Years | - | - | - |
RXRX EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs Highvs High | LowLow | Current vs Lowvs Low | |
|---|---|---|---|---|---|
| 1M | 1-Month | -3.16 | -4.8% | -4.32 | +23.4% |
| 3M | 3-Month | -2.63 | -25.9% | -4.32 | +23.4% |
| 6M | 6-Month | -2.38 | -39.1% | -4.32 | +23.4% |
| 1Y | 1-Year | -2.29 | -44.5% | -9.09 | +63.6% |
| 3Y | 3-Year | -1.93 | -71.5% | -11.70 | +71.7% |
| 5Y | 5-Year | -1.64 | -101.8% | -65.13 | +94.9% |
| All-Time | All-Time | -1.64 | -101.8% | -65.13 | +94.9% |
RXRX EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -3.31(+35.6%) |
| 2024 | -5.14(+19.4%) |
| Date | Value |
|---|---|
| 2023 | -6.38(-49.4%) |
| 2022 | -4.27(+69.0%) |
| 2021 | -13.76 |
FAQ
- What is Recursion Pharmaceuticals, Inc. EV/EBITDA?
- What is the all-time high EV/EBITDA for Recursion Pharmaceuticals, Inc.?
- What is RXRX EV/EBITDA year-to-date change?
- What is Recursion Pharmaceuticals, Inc. EV/EBITDA year-on-year change?
What is Recursion Pharmaceuticals, Inc. EV/EBITDA?
The current EV/EBITDA of RXRX is -3.31
What is the all-time high EV/EBITDA for Recursion Pharmaceuticals, Inc.?
Recursion Pharmaceuticals, Inc. all-time high EV/EBITDA is -1.64
What is RXRX EV/EBITDA year-to-date change?
Recursion Pharmaceuticals, Inc. EV/EBITDA has changed by +1.83 (+35.60%) since the beginning of the year
What is Recursion Pharmaceuticals, Inc. EV/EBITDA year-on-year change?
Over the past year, RXRX EV/EBITDA has changed by +0.95 (+22.30%)